Public beta Β· Read before use
Use only with the support of verified AiAmbA engineers
- This is a public beta testing version β unfinished software and hardware made available for a limited testing period. It is provided without any warranty or guarantee of any kind.
- It may be used only with the support of verified engineers of AiVibe's AI Factory team (AiAmbA) who have product-handling expertise for your installation.
- Machines may include medical devices with controllers. AiVibe does not recommend giving any instruction to a machine or medical device unless the person giving it holds the required certification and hands-on training experience for that exact machine or device. Controlling a medical device is outside the intended purpose of the beta.
- Answers and proposals in the AiCippY app are generated by AI systems, not by a person.
- The public beta is not cleared, approved, CE-marked or UKCA-marked as a medical device, must not be used as one, and is not a safety function.
- All disputes worldwide are subject to the exclusive jurisdiction of the courts at Chennai, Tamil Nadu, India.
- Document:
- AIV-IFU-AIF-001
- Revision:
- Public Beta B1
- Effective:
- 8 October 2026
- Language:
- English (controlling version)
- Manufacturer (OEM):
- AiVibe Software Services Private Limited, Chennai, Tamil Nadu, India
1. Product description
The AiAmbA AI Factory is a natural-language communication bridge between people and machines, designed and manufactured by AiVibe as the OEM. It consists of:
- AiAmbA edge devices such as the compact AiAmbA N Series 150, with built-in networking, which connect to a machine's controller (for example PLC, CNC or robot controllers) on the factory network;
- the AiCippY app (mobile) through which authorised operators chat with their machines by text or voice;
- cloud AI agents that interpret requests, read telemetry and documents, and prepare proposed actions for human confirmation; and
- a desktop commissioning tool used only by verified AiAmbA engineers.
The AI Factory helps people understand and operate equipment faster. It does not replace the machine's control system, its safety systems, the manufacturer's instructions or the judgement of a qualified person.
Minimum requirements
- AiCippY app: Android 16 (API level 36) or later, or iOS 18 or later.
- A segmented factory network for the AiAmbA edge device, with outbound encrypted (TLS) internet access to AiVibe's cloud, including secure WebSocket connections.
- An organisation account issued by AiVibe, with individual sign-in for every user.
- A commissioning record signed by a verified AiAmbA engineer for each connected machine.
2. AI agents used by the communication bridge
Depending on the deployment a customer chooses, the bridge uses one or more of the following agent technologies. Each is used only as a language and reasoning layer; none of them is given direct control of a machine.
AiCippY agent
AiVibe's own natural-language agent in the AiCippY app β it reads machine telemetry, answers questions with cited sources and prepares change requests for human confirmation.
Google ADK agents
Specialist agents built with Google's open-source Agent Development Kit (ADK) β sourcing, controller programming, drawings and metrology, tooling and process, and operations.
Google Gemini agents & GEAR
Google Gemini models for text and live voice conversation, and agents on Google's Gemini Enterprise Agent Platform built with skills from Google's GEAR (Gemini Enterprise Agent Ready) programme, where a customer chooses Google Cloud.
NVIDIA agents
NVIDIA agent tooling and models β for example the NeMo Agent Toolkit, NVIDIA NIM microservices and Isaac GR00T robot foundation models β for on-premises or edge inference, vision and robotics workloads.
AWS Bedrock AgentCore
Amazon Bedrock AgentCore as a managed runtime, memory, tool gateway, identity and observability layer when a deployment is hosted on AWS.
Open-source agents in the cloud
Open-source agent frameworks and models hosted in a customer's or AiVibe's cloud tenancy, connected through open protocols such as the Model Context Protocol (MCP) and Agent2Agent (A2A).
Third-party models, agents and cloud services are provided under their providers' own terms. Naming them does not imply that Google, NVIDIA, Amazon Web Services or any other provider endorses, certifies or is responsible for the AiAmbA AI Factory.
3. Intended use (public beta)
Within the public beta, the AiAmbA AI Factory is intended for:
- Reading and explaining machine status, alarms and production telemetry in plain language (English first).
- Finding and citing information in documents a customer has uploaded (manuals, drawings, NC programs, SOPs).
- Preparing change requests for parameters that a verified AiAmbA engineer has explicitly commissioned, which a trained operator must review and confirm before anything is sent.
- Supervised pilots and evaluation of natural-language interaction with industrial machines and controllers (PLCs, CNC and robot controllers).
Intended users: business and professional users only β trained, certified machine operators, maintenance and process engineers, and (for the limited medical-device conditions below) qualified clinical or biomedical engineers, each supported by a verified AiAmbA engineer. The beta is not offered to consumers.
Intended environment: supervised industrial pilot installations where the machine remains fully operable and safe through its own local controls.
4. Prohibited uses and contraindications
Do not use the AiAmbA AI Factory for any of the following:
- Diagnosis, prevention, monitoring, prediction, prognosis, treatment or alleviation of any disease, injury or disability, or any other medical purpose. The public beta is not cleared or approved for any medical use.
- Controlling, adjusting or commanding any life-supporting or life-sustaining equipment, or any medical device while it is connected to or in use on a patient (for example ventilators, infusion pumps, anaesthesia, dialysis, defibrillators, imaging or radiotherapy equipment).
- Any safety function. The AI bridge does not replace emergency stops, interlocks, guards, light curtains, safety PLCs or lockout/tagout. A software "stop" request is not a safety-rated stop.
- Unattended, autonomous or closed-loop operation without a trained person present at the machine.
- Use by anyone without valid certification and hands-on training for the specific machine or device, or without the support of a verified AiAmbA engineer.
- Lockout/tagout, energy isolation, or work inside a machine's hazard zone based on information from the AI.
- Hazardous (explosive) atmospheres or other environments the edge device is not rated for.
- Overriding, bypassing or contradicting the original equipment manufacturer's instructions for use. The machine maker's IFU always takes priority.
- Entering patient-identifiable or other special-category health data into the public beta.
5. Machines that are medical devices with controllers
Some machines are medical devices with their own controllers. Connecting any software to such a device can change its intended purpose, its regulatory status and the safety of patients and users. The public beta is not cleared or approved as a medical device or as an accessory to one, so:
- Sending instructions (commands) to a medical device is outside the intended purpose of the beta and is not recommended. It must never be attempted by anyone who does not hold the device manufacturer's certification and hands-on training for that model.
- Software that drives or influences a medical device is regulated together with that device (for example under the EU MDR and by the U.S. FDA). Using the bridge to control a medical device would therefore be use outside its intended purpose and outside its regulatory status.
- Any interaction with a medical device's controller is limited to non-clinical technical work β for example reading service status or diagnostic codes in a workshop β with the device disconnected from any patient. Clinical use is prohibited.
- A connection may be made only with the written authorisation of the device's legal manufacturer and the healthcare organisation's clinical/biomedical engineering function, after a documented risk assessment (for example to ISO 14971 and IEC 80001-1).
- Only people who hold the manufacturer's certification and hands-on training for that exact device model may be involved, together with a verified AiAmbA engineer.
- The device manufacturer's IFU, service manual and the healthcare organisation's procedures always take priority over anything the AI says.
6. Who may use it: certification, training and verified engineers
- Operators must hold current certification and hands-on training for the specific machine or device, be authorised by their employer, and complete AiAmbA AI Factory beta onboarding.
- Verified AiAmbA engineers are AiVibe AI Factory engineers with product-handling expertise who are named to you in writing by AiVibe. Before allowing anyone to commission or service an installation, confirm their identity at support@aivibe.in. AiVibe never asks for passwords or one-time codes.
- Commissioning, parameter mapping and any change to enabled write parameters may be done only by a verified AiAmbA engineer together with the customer's responsible engineer.
7. How the natural-language bridge works β and its built-in safeguards
- 1
Ask in plain language
The operator asks a question by text or voice in the AiCippY app, e.g. "Why did spindle 2 alarm at 10:40?"
- 2
Agent reads, never guesses silently
The agent reads live telemetry from the AiAmbA edge device and the customer's own documents, and answers with its sources. Unsupported controller dialects, macros or cycles are reported as unsupported rather than interpreted.
- 3
Changes are only proposed
Agents cannot write to a machine directly. A change becomes a proposal tied to one organisation, one operator, one device and one exact value β shown as ACTION CONFIRMATION REQUIRED.
- 4
Human confirmation within 60 seconds
The operator must review the device, parameter and value and confirm (slide-to-confirm) within 60 seconds. Each confirmation can be used once. Unconfirmed or foreign approvals are rejected.
- 5
Commissioned bounds re-checked
Only parameters a verified AiAmbA engineer has enabled β with a minimum, maximum and verified address β can be requested. Everything else is denied by default.
- 6
Expiry, no silent retries
A queued command expires after 30 seconds. A command sent without a receipt is not retried automatically.
- 7
Verified only on read-back
A change is shown as verified only when the machine reports back the requested value. Always confirm on the machine's own HMI.
Beta limitation: availability of write functions depends on commissioning, and some controller protocols and write paths are not yet enabled in the public beta. Treat every capability as limited until a verified AiAmbA engineer confirms it for your installation in writing.
8. Before each use β checklist
- The machine's own emergency stop, guards and interlocks are working and within reach.
- You hold current certification and hands-on training for this specific machine or device.
- A verified AiAmbA engineer has commissioned this installation and is reachable during use.
- The commissioned parameter map still matches the machine β re-verify after any retrofit, firmware update, controller replacement or program change.
- The AiCippY app and AiAmbA device firmware are the versions supplied for the beta, and the app shows the device as connected.
- Nobody is inside the machine's hazard zone, and the machine can be operated safely locally if the network or cloud is unavailable.
If any item cannot be confirmed, do not use the AI bridge with that machine.
9. Warnings and cautions
WARNING β could result in death or serious injury. CAUTION β could result in minor injury or damage to equipment, product or data.
- WARNING: AI output can be wrong, incomplete or out of date. Check every answer against the machine's HMI, the manufacturer's documentation and your own professional judgement before acting.
- WARNING: Never use the AI bridge in an emergency. Use the machine's hardwired emergency stop.
- WARNING: Never confirm an action you did not request, do not fully understand, or that names a different device or value than you expect.
- WARNING: Never give an instruction to a medical device that is connected to or in use on a patient, and never without the manufacturer's certification and training for that device. See section 5.
- CAUTION: Network or cloud interruptions can delay or drop messages. Do not depend on the bridge for time-critical actions.
- CAUTION: Speech recognition can mishear in noisy areas. Always read the confirmation screen before confirming.
- CAUTION: Use only your own account. Never share sign-in credentials or confirm actions on someone else's behalf.
- CAUTION: Install, power and mount the AiAmbA edge device only as instructed by the verified AiAmbA engineer, within the environmental limits supplied for your installation.
10. Installation and commissioning (verified AiAmbA engineers only)
- Identify the device, configure the factory network and the controller address, and label the device.
- Connect read-only first. Map only the signals needed, using the actual machine's verified memory map β never a generic or example register map.
- Enable a write parameter only when the customer's responsible engineer approves it, with an explicit minimum, maximum and verified address. Everything not enabled stays denied.
- Test each enabled parameter at the machine with the operator present, and record the read-back.
- Record the commissioning in a signed checklist; the customer keeps a copy.
11. Cybersecurity and data protection
- Sign-in uses AiVibe's enterprise identity service with Google sign-in, and every user acts under their own account. Each organisation's data, devices and conversations are isolated from every other organisation's.
- Communications are logged for audit and safety review; credentials, approval tokens and raw voice audio are excluded from those logs.
- Keep the AiCippY app, operating system and AiAmbA firmware at the versions supplied, place edge devices on a segmented factory network, and remove access for people who leave.
- Do not upload patient-identifiable or other special-category health data to the public beta. Personal data is handled as described in our Privacy Policy; privacy requests: privacy@aivibe.in.
- Report suspected security issues immediately to support@aivibe.in.
12. Regulatory status for users in the EU, UK and USA
EUEuropean Union
- The AiAmbA AI Factory is not CE-marked as a medical device under Regulation (EU) 2017/745 (MDR), and the public beta must not be used as a medical device or as an accessory to one.
- Connecting it to a medical device can change that device's intended purpose and conformity status; this remains the responsibility of the device's legal manufacturer and the health institution.
- Under the EU AI Act (Regulation (EU) 2024/1689, as amended), AI that is a safety component of products such as medical devices or machinery is high-risk. The public beta must not be used in that role, and users are told when they are interacting with an AI system.
- Machinery placed on the EU market is subject to the Machinery Regulation (EU) 2023/1230 (applicable from 20 January 2027). The beta is not a safety component of any machine.
- Personal data is processed under the GDPR; do not process health data in the beta. Mandatory consumer and product-liability rights under EU law, including the Product Liability Directive (EU) 2024/2853, are not affected.
UKUnited Kingdom
- The AiAmbA AI Factory is not UKCA- or CE-marked as a medical device and is not registered with the MHRA under the UK Medical Devices Regulations 2002.
- In Northern Ireland, EU MDR rules apply to medical devices.
- Any integration with a medical device remains the responsibility of the device's manufacturer and the healthcare organisation; report device incidents to the MHRA through the Yellow Card scheme.
- Personal data is processed under the UK GDPR and the Data Protection Act 2018. Statutory rights that cannot be excluded under UK law are not affected.
USUnited States
- The AiAmbA AI Factory has not been cleared, approved or otherwise authorised by the U.S. Food and Drug Administration (FDA). The AiAmbA device's GUDID (unique device identification) record is a listing only β not FDA clearance or approval β and does not extend the intended use described in this notice.
- It is not intended for clinical decision support or any use in patient care. FDA regulates software that controls a medical device as a device, so controlling medical devices is outside the beta's intended use. Do not process protected health information (PHI) in the public beta.
- The AI bridge is not an energy-isolating device and must never be used for lockout/tagout under OSHA 29 CFR 1910.147 or in place of machine guarding.
- Report medical device problems to the device manufacturer and, where required, to the FDA through MedWatch.
INIndia (manufacturer)
- AiVibe Software Services Private Limited designs and manufactures (OEM) the AiAmbA AI Factory in Chennai, Tamil Nadu.
- The beta is not registered or licensed as a medical device under India's Medical Devices Rules, 2017.
This notice summarises AiVibe's position for the public beta. It is not legal advice. Customers remain responsible for meeting the laws that apply to their own machines, devices, workplaces and data.
13. Reference standards (informative)
AiVibe uses the following standards as references when designing the beta and when advising customers on safe integration. Listing a standard is not a claim that the beta conforms to it, except where stated.
- ISO 12100 β machinery risk assessment and risk reduction
- ISO 13849-1 / IEC 62061 β safety-related parts of control systems (safety functions stay outside the AI bridge)
- IEC 61508 β functional safety of electrical/electronic/programmable systems
- ISO 10218-1/-2 β industrial robot safety
- IEC 62443 β security for industrial automation and control systems
- ISO 14971 β risk management for medical devices
- IEC 80001-1 β risk management for IT networks that incorporate medical devices
- IEC 62304 / IEC 81001-5-1 β medical device software life cycle and security
- ISO/IEC 27001 β information security management (AiVibe is ISO/IEC 27001:2022 certified)
- ISO/IEC 42001 β AI management systems
14. Incident reporting and support
- Stop using the AI bridge and bring the machine to a safe state using its own controls.
- Do not try to reproduce the problem on a live machine.
- Inform your verified AiAmbA engineer and email support@aivibe.in with the date, time, device label and what happened.
- If a medical device was involved, also report to its manufacturer and, where required, to the competent authority (EU national competent authority, the MHRA Yellow Card scheme in the UK, or FDA MedWatch in the USA).
15. No warranty, no guarantee, limitation of liability
The AiAmbA AI Factory public beta β hardware, software, AI agents, outputs and documentation β is provided "as is" and "as available", without warranty or guarantee of any kind, whether express, implied or statutory, including any warranty of merchantability, fitness for a particular purpose, accuracy, availability, uninterrupted or error-free operation, or non-infringement. AiVibe does not guarantee any result, output, production outcome or saving.
To the maximum extent permitted by law, AiVibe Software Services Private Limited, AIVEDHA INC and their affiliates, directors, employees and partners are not liable for any indirect, incidental, special, consequential or punitive loss, or for loss of production, profit, data, equipment or goodwill, arising from use of or reliance on the beta. Features may change, be suspended or be withdrawn at any time.
Nothing in this notice excludes or limits liability that cannot be excluded or limited under applicable law, such as liability for death or personal injury caused by negligence, liability for fraud, or mandatory product-liability law.
16. Governing law and exclusive jurisdiction β Chennai, India
This notice, the public beta and every dispute or claim arising from or connected with them, anywhere in the world, are governed by the laws of India. The courts at Chennai, Tamil Nadu, India (including the High Court of Judicature at Madras) have exclusive jurisdiction, and users in the European Union, the United Kingdom, the United States and all other countries submit to that jurisdiction.
Use of the public beta requires acceptance of this notice and our Terms & Conditions during onboarding. Where a mandatory law of a user's country gives rights that cannot be waived by contract, those rights are not affected.
Legal notices: legal@aivibe.in. See also our Terms & Conditions.
17. Document control and trademarks
| Revision | Date | Change |
|---|---|---|
| Public Beta B1 | 8 October 2026 | First publication for the AiAmbA AI Factory public beta (EU, UK, USA). |
The latest version of this document is always at www.aivibe.in/regulatory/ifu. Printed copies are uncontrolled. If a translation differs from this English version, the English version applies.
AiAmbA, AiCippY and AiVibe are trademarks of AiVibe Software Services Private Limited. Google, Gemini and Google Cloud are trademarks of Google LLC; NVIDIA, NeMo and Isaac are trademarks of NVIDIA Corporation; Amazon Web Services, AWS and Amazon Bedrock are trademarks of Amazon.com, Inc. or its affiliates. Other names are the property of their respective owners.
Planning an AI Factory pilot? Talk to a verified AiAmbA engineer before you connect any machine.
